BioCentury | Apr 25, 2019
Emerging Company Profile

miR Scientific: spotting aggression with RNA in urine

...of Danaher Corp. have bladder cancer tests based on detection of five mRNAs; and the Exosome Diagnostics Inc....
BioCentury | Sep 7, 2018
Financial News

Exosome play Evox aims for clinic with £35.5M series B

...company is one of several developing exosome-based programs, including Codiak BioSciences Inc. (Cambridge, Mass.) and Exosome Diagnostics Inc....
BioCentury | Sep 4, 2018
Financial News

Exosome play Evox aims for clinic with £35.5M series B

...company is one of several developing exosome-based programs, including Codiak BioSciences Inc. (Cambridge, Mass.) and Exosome Diagnostics Inc....
BioCentury | Jun 29, 2018
Company News

Bio-Techne acquiring Exosome Diagnostics for $250M

...Research supplier Bio-Techne Corp. (NASDAQ:TECH) will acquire cancer diagnostic company Exosome Diagnostics Inc. (Waltham, Mass.) for $250 million...
...exosomes and is used to predict whether men have high-risk prostate cancer prior to biopsy. Exosome Diagnostics Inc....
...NASDAQ:TECH), Minneapolis, Minn. Business: Diagnostic, Cancer Jaime De Leon ExoDx Prostate(IntelliScore), Prostate cancer liquid biopsy test (exo106) Bio-Techne Corp. Exosome Diagnostics Inc....
BioCentury | Jun 26, 2018
Company News

Bio-Techne acquiring Exosome Diagnostics for $250M

...Research supplier Bio-Techne Corp. (NASDAQ:TECH) will acquire cancer diagnostic company Exosome Diagnostics Inc. (Waltham, Mass.) for $250 million...
...off $1.22 to $157.03 on Tuesday. Jaime De Leon ExoDx Prostate(IntelliScore), Prostate cancer liquid biopsy test (exo106) Bio-Techne Corp. Exosome Diagnostics Inc....
BioCentury | Aug 31, 2017
Translation in Brief

Bringing home exosomes

...make it available for point-of-care diagnostics. At least six companies are pursuing exosome-based diagnostics, including Exosome Diagnostics Inc....
...exosomes and associated biomarkers from plasma." ACS Nano (2017) Mark Zipkin, Staff Writer Biological Dynamics Inc. Codiak BioSciences Inc. Exosome Diagnostics Inc. University...
BioCentury | Jun 22, 2017
Targets & Mechanisms

Exosomes deliver

...of the cells that shed them. The first exosome-based diagnostic was launched last year by Exosome Diagnostics Inc....
...from his lab identifying GPC1 as a biomarker on exosomes released from pancreatic cancer cells. Exosome Diagnostics...
...A new extracellular vesicle detection system developed at Massachusetts General Hospital has been licensed to Exosome Diagnostics Inc....
BioCentury | Jun 22, 2017
Distillery Techniques

Assays and screens; biomarkers

...higher than in vesicles from the 8 patients with other abdominal indications. Next steps by Exosome Diagnostics Inc....
...from plasmas for diagnosing pancreatic ductal adenocarcinoma (PDAC) LICENSING STATUS: Patent application filed; licensed to Exosome Diagnostics Inc....
...online May 24, 2017 doi:10.1126/scitranslmed.aal3226 CONTACT: Ralph Weissleder, Massachusetts General Hospital, Boston, Mass. email: rweissleder@mgh.harvard.edu Hongjiang Li Exosome Diagnostics Inc. Massachusetts...
BioCentury | May 26, 2017
Emerging Company Profile

Bypassing biopsies

...diagnostic. At least one company already markets a prostate cancer test based on tumor-derived vesicles. Exosome Diagnostics Inc....
...the functional consequence of those changes as they relate to things like metastases,” Lewis said. Exosome Diagnostics...
...John Lewis Patents: None issued Companies and Institutions Mentioned Freenome Inc., South San Francisco, Calif. Exosome Diagnostics Inc....
BioCentury | Mar 24, 2017
Clinical News

Donor exosomes could provide an early warning of transplant failure

...patents on the technology are available for licensing and the university is seeking commercial partners. Michael Leviten Exosome Diagnostics University...
Items per page:
1 - 10 of 54
BioCentury | Apr 25, 2019
Emerging Company Profile

miR Scientific: spotting aggression with RNA in urine

...of Danaher Corp. have bladder cancer tests based on detection of five mRNAs; and the Exosome Diagnostics Inc....
BioCentury | Sep 7, 2018
Financial News

Exosome play Evox aims for clinic with £35.5M series B

...company is one of several developing exosome-based programs, including Codiak BioSciences Inc. (Cambridge, Mass.) and Exosome Diagnostics Inc....
BioCentury | Sep 4, 2018
Financial News

Exosome play Evox aims for clinic with £35.5M series B

...company is one of several developing exosome-based programs, including Codiak BioSciences Inc. (Cambridge, Mass.) and Exosome Diagnostics Inc....
BioCentury | Jun 29, 2018
Company News

Bio-Techne acquiring Exosome Diagnostics for $250M

...Research supplier Bio-Techne Corp. (NASDAQ:TECH) will acquire cancer diagnostic company Exosome Diagnostics Inc. (Waltham, Mass.) for $250 million...
...exosomes and is used to predict whether men have high-risk prostate cancer prior to biopsy. Exosome Diagnostics Inc....
...NASDAQ:TECH), Minneapolis, Minn. Business: Diagnostic, Cancer Jaime De Leon ExoDx Prostate(IntelliScore), Prostate cancer liquid biopsy test (exo106) Bio-Techne Corp. Exosome Diagnostics Inc....
BioCentury | Jun 26, 2018
Company News

Bio-Techne acquiring Exosome Diagnostics for $250M

...Research supplier Bio-Techne Corp. (NASDAQ:TECH) will acquire cancer diagnostic company Exosome Diagnostics Inc. (Waltham, Mass.) for $250 million...
...off $1.22 to $157.03 on Tuesday. Jaime De Leon ExoDx Prostate(IntelliScore), Prostate cancer liquid biopsy test (exo106) Bio-Techne Corp. Exosome Diagnostics Inc....
BioCentury | Aug 31, 2017
Translation in Brief

Bringing home exosomes

...make it available for point-of-care diagnostics. At least six companies are pursuing exosome-based diagnostics, including Exosome Diagnostics Inc....
...exosomes and associated biomarkers from plasma." ACS Nano (2017) Mark Zipkin, Staff Writer Biological Dynamics Inc. Codiak BioSciences Inc. Exosome Diagnostics Inc. University...
BioCentury | Jun 22, 2017
Targets & Mechanisms

Exosomes deliver

...of the cells that shed them. The first exosome-based diagnostic was launched last year by Exosome Diagnostics Inc....
...from his lab identifying GPC1 as a biomarker on exosomes released from pancreatic cancer cells. Exosome Diagnostics...
...A new extracellular vesicle detection system developed at Massachusetts General Hospital has been licensed to Exosome Diagnostics Inc....
BioCentury | Jun 22, 2017
Distillery Techniques

Assays and screens; biomarkers

...higher than in vesicles from the 8 patients with other abdominal indications. Next steps by Exosome Diagnostics Inc....
...from plasmas for diagnosing pancreatic ductal adenocarcinoma (PDAC) LICENSING STATUS: Patent application filed; licensed to Exosome Diagnostics Inc....
...online May 24, 2017 doi:10.1126/scitranslmed.aal3226 CONTACT: Ralph Weissleder, Massachusetts General Hospital, Boston, Mass. email: rweissleder@mgh.harvard.edu Hongjiang Li Exosome Diagnostics Inc. Massachusetts...
BioCentury | May 26, 2017
Emerging Company Profile

Bypassing biopsies

...diagnostic. At least one company already markets a prostate cancer test based on tumor-derived vesicles. Exosome Diagnostics Inc....
...the functional consequence of those changes as they relate to things like metastases,” Lewis said. Exosome Diagnostics...
...John Lewis Patents: None issued Companies and Institutions Mentioned Freenome Inc., South San Francisco, Calif. Exosome Diagnostics Inc....
BioCentury | Mar 24, 2017
Clinical News

Donor exosomes could provide an early warning of transplant failure

...patents on the technology are available for licensing and the university is seeking commercial partners. Michael Leviten Exosome Diagnostics University...
Items per page:
1 - 10 of 54